Last edition
News about "Sharon Rosenzweig-Lipson"
Life Biosciences Reports First Human Data for ER-100 Trial
Life Biosciences has announced first-in-human data from ongoing phase 1 trial evaluating ER-100 in optic neuropathies.
Sharon Rosenzweig-Lipson | 13/10/2026 | By News Bureau
Life Biosciences Wins FDA IND Clearance for ER-100
The IND clearance allows Life Bio to initiate a clinical programme evaluating ER-100’s safety and potential to improve vision in patients with optic neuropathies.
Sharon Rosenzweig-Lipson | 29/01/2026 | By News Bureau | 2961
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy